These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8699331

  • 1. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat.
    Besret L, Debruyne D, Rioux P, Bonvalot T, Moulin M, Zarifian E, Baron JC.
    J Pharm Sci; 1996 Mar; 85(3):291-5. PubMed ID: 8699331
    [Abstract] [Full Text] [Related]

  • 2. Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study.
    Melzacka M, Danek L, Adamus A.
    Pol J Pharmacol Pharm; 1987 Mar; 39(4):379-86. PubMed ID: 3449809
    [Abstract] [Full Text] [Related]

  • 3. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA, Perini GI, Molnar G, Jusko WJ.
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL, Simpkins JW.
    Drug Metab Dispos; 1985 Feb; 13(4):438-42. PubMed ID: 2863107
    [Abstract] [Full Text] [Related]

  • 5. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M, Rurak A, Danek L, Daniel W, Vetulani J.
    Pol J Pharmacol Pharm; 1985 Feb; 37(4):525-32. PubMed ID: 4080646
    [Abstract] [Full Text] [Related]

  • 6. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z, Skuza G, Wójcikowski J, Daniel WA.
    Pol J Pharmacol; 2003 Feb; 55(6):993-9. PubMed ID: 14730094
    [Abstract] [Full Text] [Related]

  • 7. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI, Suckow RF, Cooper TB.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine.
    Daniel W, Syrek M, Janczar L, Boksa J.
    Pol J Pharmacol; 1995 Aug; 47(2):127-36. PubMed ID: 8688885
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J, Panas M, Chruściel W.
    Pol J Pharmacol Pharm; 1983 Aug; 35(2):151-7. PubMed ID: 6622297
    [Abstract] [Full Text] [Related]

  • 10. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J, Panas M, Chruściel W.
    Pol J Pharmacol Pharm; 1984 Aug; 36(1):21-6. PubMed ID: 6462958
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of lofepramine and imipramine in liver microsomes from rat and man.
    Strandgården K, Gunnarsson PO.
    Xenobiotica; 1994 Aug; 24(8):703-11. PubMed ID: 7839694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W.
    Pol J Pharmacol Pharm; 1991 Aug; 43(3):197-206. PubMed ID: 1683700
    [Abstract] [Full Text] [Related]

  • 14. The effect of prolonged administration of imipramine on its hepatic metabolism in rats.
    Daniel W, Melzacka M.
    Pol J Pharmacol Pharm; 1987 Aug; 39(2):135-41. PubMed ID: 3432159
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL, Jusko WJ.
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [Abstract] [Full Text] [Related]

  • 16. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
    Syrek M, Wójcikowski J, Daniel WA.
    Pol J Pharmacol; 1997 Apr; 49(6):453-62. PubMed ID: 9566049
    [Abstract] [Full Text] [Related]

  • 17. Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
    Rogóz Z, Dlaboga D, Dziedzicka-Wasylewska M.
    J Physiol Pharmacol; 2003 Jun; 54(2):257-70. PubMed ID: 12832726
    [Abstract] [Full Text] [Related]

  • 18. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL, Simpkins JW, Stout SA.
    Psychopharmacology (Berl); 1984 Jun; 84(2):225-30. PubMed ID: 6438681
    [Abstract] [Full Text] [Related]

  • 19. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [Abstract] [Full Text] [Related]

  • 20. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B, Holle L.
    Chronobiol Int; 1991 Nov; 8(3):176-85. PubMed ID: 1794155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.